Empraz

Empraz

omeprazole

Manufacturer:

Stallion Labs

Distributor:

Geo Pharma

Marketer:

Ambica
Concise Prescribing Info
Contents
Omeprazole Na
Indications/Uses
Benign gastric & duodenal ulcers, Zollinger-Ellison syndrome, gastric acid reduction, GERD, acid reflux disease, acid-related dyspepsia.
Dosage/Direction for Use
40 mg IV infusion over a period of 20-30 min.
Special Precautions
Consider possibility of malignancy in patients w/ gastric ulcers. Hepatic impairment.
Adverse Reactions
Headache, diarrhea & skin rashes.
Drug Interactions
May alter metabolism of drugs metabolized by CYP2C19. May prolong the elimination of diazepam, phenytoin & warfarin. Reduce the absorption of ketoconazole & possibly, itraconazole. Increased plasma conc w/ & of voriconazole.
ATC Classification
A02BC01 - omeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Empraz powd for inj 40 mg
Packing/Price
(+ 10 mL diluent) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in